Phase I trial of CX-5461, a first-in-class G-quadruplex stabilizer in patients with advanced solid tumors enriched for DNA-repair deficiencies (CCTG IND.231) - Variant Calls
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://zenodo.org/record/6403005
下载链接
链接失效反馈官方服务：
资源简介：
Variant Calls from Phase I trial of CX-5461, a first-in-class G-quadruplex stabilizer in patients with advanced solid tumors enriched for DNA-repair deficiencies (CCTG IND.231)
See publication for methodology.
创建时间：
2022-05-14
